Why the study?
Does low molecular weight heparin safely prevent and treat thromboembolism in pregnant women?
Population
6 pregnant women requiring treatment or prophylaxis of thromboembolism
Design
Case_series
Follow-up
Through pregnancy and puerperium
Authors
Loading...
May support LMWH consideration in pregnancy; leaves open need for prospective validation.
Does low molecular weight heparin safely prevent and treat thromboembolism in pregnant women?
Low molecular weight heparin appears to be a safe and effective alternative to standard heparin for thromboembolism prophylaxis and treatment during pregnancy.
Gillis et al. (1992) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: